Bluepharma, InovCapital and the University of Coimbra (UC) license and sponsor Luzitin

The University of Coimbra (UC), the pharmaceutical company Bluepharma and the venture capitalist investor InovCapital will sign a technology licensing and funding agreement with Luzitin, a new spin-off company of the University of Coimbra, which will thus lead the next stage of a promising research in the photodynamic therapy against cancer.

«After validating the technical concept and following the success observed in the first animal testing rounds, the process will enter a decisive stage towards the development of a more effective medicine.